Skip to content

A study to evaluate the effect of a combination Giloy Gomutra Capsules, Asthi Churna and Kamdhenu Asava in COVID-19

A Clinical Evaluation of the combination Giloy Gomutra Capsules, Asthi Churna and Kamdhenu Asava in the Management of the Pandemic- Covid-19.Â

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/07/026353
Enrollment
30
Registered
2020-07-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: 1)Giloy Gaumutra Capsules 2)Asthi Churna 3)Kamdhenu Aasava: All the three drugs will be given to all patients , it will be single experimental group. This Ayurvedic treatment will be

Sponsors

Bansi Gir Gaushala
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age: >16 years Patient having Covid-19 positive and Home quarantined patients with signs and symptoms of Covid-19.

Exclusion criteria

Exclusion criteria: Age: 60 years. Pregnant women and lactating mother Severe cases of Covid-19 like associated Pneumonia, COPD, and other severe associated diseases. Patient on ventilator. Uncontrolled Diabetes Mellitus & Hypertension Any other serious systemic illness like AIDS, Malignancy etc. Patients who are not willing to be included in the studyÂ

Design outcomes

Primary

MeasureTime frame
Investigations of Covid-19 will be done before and After the treatment. Also symptoms will be given gradation and checked on before and after treatment.Timepoint: Investigations of Covid-19 will be done before and After the treatment. Also symptoms will be given gradation and checked on first, seventh and fifteenth day of the treatment.

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr Dineshchandra Pandya

Neuropanch Ayurved Hospital and Research Organization

urvipandya18@gmail.com9638300839

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026